Toshiyuki Nakamura

An exploratory retrospective multicenter study of prognostic factors in mCRPC patients undergoing enzalutamide treatment: Focus on early PSA decline and kinetics at time of progression

H. Nakayama, Y. Shibata, Y. Sekine, 2019, The Prostate.

A Prospective Study of the Relationship Between Clinical Outcomes After Enzalutamide and Serum Androgen Levels Measured via Liquid Chromatography-tandem Mass Spectrometry in Patients with Castration-resistant Prostate Cancer

Y. Sekine, Y. Miyazawa, Kazuhiro Suzuki, 2021, European urology open science.

[Symptoms of prostate cancer that required treatment in the terminal stage for two years].

H. Okazaki, Toshiyuki Nakamura, H. Okugi, 2010, Hinyokika kiyo. Acta urologica Japonica.

A prospective study of the relationship between CRPC patient's quality of life after enzalutamide and serum testosterone levels measured via LC‐MS/MS

Y. Sekine, Y. Miyazawa, Kazuhiro Suzuki, 2022, The Prostate.

INVESTIGATION OF PROSTATE-SPECIFIC ANTIGEN IN PROSTATE CANCER. DETECTION OF EARLY PROSTATE CANCER.

H. Okazaki, Toshiyuki Nakamura, K. Saito, 1996 .

[Prostate cancer screening at Tatebayashi City in Gunma prefecture--results of screening with PSA alone between 2003 and 2005].

Takumi Yamamoto, T. Nitta, Kazuhiro Suzuki, 2007, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

An exploratory retrospective multicenter study of prognostic factors in mCRPC patients undergoing enzalutamide treatment: Focus on early PSA decline and kinetics at time of progression

H. Nakayama, Y. Shibata, Y. Sekine, 2019, The Prostate.

[IPSILATERAL SYNCHRONOUS FUMARATE HYDRATASE-DEFICIENT RENAL CELL CARCINOMA AND MULTILOCULAR CYSTIC RENAL NEOPLASM OF LOW MALIGNANT POTENTIAL: A CASE REPORT AND LITERATURE REVIEW].

H. Okazaki, H. Ikota, Toshiyuki Nakamura, 2022, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.